Shanghai Fosun Pharmaceutical (Group) , Ltd. Profit Margin

As of the most recent data (September 2026), SFOSF shows a profit margin of 8.33%. That compares with 8.3% in the prior-year period — up 0.4% year over year. That is below the sector sector average of 13.23%. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, SFOSF's profit margin is now 8.33% (was 8.3%) — a 0.4% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Shanghai Fosun Pharmaceutical (Group) , Ltd. is outperforming or lagging.

The its sector sector average profit margin is about 13.23%. Shanghai Fosun Pharmaceutical (Group) , Ltd. is at 8.33%, which is lower that average. That is roughly 37.0% below the sector mean. Use the comparison chart on this page to see how SFOSF stacks up against individual peers as well.

That compares with 8.3% in the prior-year period — up 0.4% year over year. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Shanghai Fosun Pharmaceutical (Group) , Ltd. with peers to see if the move is company-specific or sector-wide.

Besides this profit margin page, Stockcircle has Shanghai Fosun Pharmaceutical (Group) , Ltd.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect profit margin (currently 8.33%) with ownership activity and broader fundamentals.